{ "cik": 1088856, "cik_padded": "0001088856", "entityName": "CORCEPT THERAPEUTICS INC", "fiscal_years": [ { "accn": "0001628280-26-011091", "filed": "2026-02-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 172915000.0, "capex": 211000.0, "cash": 120495000.0, "eps_diluted": 0.82, "free_cash_flow": 141785000.0, "net_income": 99652000.0, "operating_cash_flow": 141996000.0, "operating_income": 44797000.0, "revenue": 761407000.0, "stockholders_equity": 647805000.0, "total_assets": 836651000.0, "total_liabilities": 188846000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.29151673728977084, "net_margin": 0.13087875472644722, "operating_margin": 0.058834499814159835, "revenue_growth_yoy": 0.12794352927233943, "roa_avg2y": 0.11883110223920286, "roa_period_end": 0.1191082064086459, "roe_avg2y": 0.15014682905000323, "roe_period_end": 0.15383024212533092 } }, { "accn": "0001628280-26-011091", "filed": "2026-02-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 15664000.0, "capex": 2172000.0, "cash": 127665000.0, "eps_diluted": 1.23, "free_cash_flow": 196123000.0, "net_income": 141209000.0, "operating_cash_flow": 198295000.0, "operating_income": 136951000.0, "revenue": 675040000.0, "stockholders_equity": 679589000.0, "total_assets": 840553000.0, "total_liabilities": 160964000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2368549226076349, "net_margin": 0.20918612230386346, "operating_margin": 0.20287834794975113, "revenue_growth_yoy": 0.39940917336097437, "roa_avg2y": 0.19316311804496364, "roa_period_end": 0.16799535543862196, "roe_avg2y": 0.23806746051147523, "roe_period_end": 0.20778588234947887 } }, { "accn": "0001628280-26-011091", "filed": "2026-02-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 139000.0, "cash": 135551000.0, "eps_diluted": 0.94, "free_cash_flow": 126542000.0, "net_income": 106140000.0, "operating_cash_flow": 126681000.0, "operating_income": 107282000.0, "revenue": 482375000.0, "stockholders_equity": 506705000.0, "total_assets": 621517000.0, "total_liabilities": 114812000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.22658548859790215, "net_margin": 0.2200362788287121, "operating_margin": 0.2224037315366675, "revenue_growth_yoy": 0.2003618193491233, "roa_avg2y": 0.17617372382353746, "roa_period_end": 0.17077569881435262, "roe_avg2y": 0.21048101873289, "roe_period_end": 0.2094709939708509 } }, { "accn": "0001628280-26-011091", "filed": "2026-02-24", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 413000.0, "cash": 66329000.0, "eps_diluted": 0.87, "free_cash_flow": 119910000.0, "net_income": 101418000.0, "operating_cash_flow": 120323000.0, "operating_income": 112634000.0, "revenue": 401858000.0, "stockholders_equity": 501842000.0, "total_assets": 583430000.0, "total_liabilities": 81588000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.16257706608852984, "net_margin": 0.2523727286753032, "operating_margin": 0.28028308506985056, "revenue_growth_yoy": 0.09803867992065096, "roa_avg2y": 0.20138881993991178, "roa_period_end": 0.1738306223540099, "roe_avg2y": 0.23111315698320967, "roe_period_end": 0.20209149493266806 } }, { "accn": "0001628280-25-008167", "filed": "2025-02-26", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 469000.0, "cash": 77617000.0, "eps_diluted": 0.89, "free_cash_flow": 167423000.0, "net_income": 112512000.0, "operating_cash_flow": 167892000.0, "operating_income": 124477000.0, "revenue": 365978000.0, "stockholders_equity": 375806000.0, "total_assets": 423756000.0, "total_liabilities": 47950000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.127592428008068, "net_margin": 0.3074283153632186, "operating_margin": 0.3401215373601692, "revenue_growth_yoy": 0.03420426479481398, "roa_avg2y": 0.22604413719114363, "roa_period_end": 0.2655112847959675, "roe_avg2y": 0.2502646961999413, "roe_period_end": 0.2993885142866266 } }, { "accn": "0001628280-24-005055", "filed": "2024-02-15", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 9945000.0, "capex": 1238000.0, "cash": 76190000.0, "eps_diluted": 0.85, "free_cash_flow": 150732000.0, "net_income": 106011000.0, "operating_cash_flow": 151970000.0, "operating_income": 128202000.0, "revenue": 353874000.0, "stockholders_equity": 523338000.0, "total_assets": 571731000.0, "total_liabilities": 48393000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09246987606479942, "net_margin": 0.2995727292765222, "operating_margin": 0.3622814900218722, "revenue_growth_yoy": 0.15461717664102112, "roa_avg2y": 0.21546009676406416, "roa_period_end": 0.18542111587442345, "roe_avg2y": 0.23702320797746276, "roe_period_end": 0.20256698347912822 } }, { "accn": "0001628280-23-005581", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 30975000.0, "capex": 1088000.0, "cash": 31269000.0, "eps_diluted": 0.77, "free_cash_flow": 135029000.0, "net_income": 94181000.0, "operating_cash_flow": 136117000.0, "operating_income": 111606000.0, "revenue": 306486000.0, "stockholders_equity": 371182000.0, "total_assets": 412312000.0, "total_liabilities": 41130000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11080817496538087, "net_margin": 0.30729299217582534, "operating_margin": 0.36414713885789235, "revenue_growth_yoy": 0.21985934160407886, "roa_avg2y": 0.26016635221255074, "roa_period_end": 0.22842168066900792, "roe_avg2y": 0.2911025802702669, "roe_period_end": 0.25373267022646573 } }, { "accn": "0001628280-22-002714", "filed": "2022-02-15", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 23657000.0, "capex": 298000.0, "cash": 41625000.0, "eps_diluted": 0.6, "free_cash_flow": 115367000.0, "net_income": 75410000.0, "operating_cash_flow": 115665000.0, "operating_income": 89496000.0, "revenue": 251247000.0, "stockholders_equity": 275882000.0, "total_assets": 311694000.0, "total_liabilities": 35812000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12980912129098673, "net_margin": 0.30014288727825605, "operating_margin": 0.35620723829538264, "revenue_growth_yoy": 0.5781747602087927, "roa_avg2y": 0.2833731969765008, "roa_period_end": 0.2419360013346423, "roe_avg2y": 0.3230587983292278, "roe_period_end": 0.2733415010765472 } }, { "accn": "0001628280-21-002861", "filed": "2021-02-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 419000.0, "cash": 31062000.0, "eps_diluted": 1.04, "free_cash_flow": 60516000.0, "net_income": 129122000.0, "operating_cash_flow": 60935000.0, "operating_income": 52855000.0, "revenue": 159201000.0, "stockholders_equity": 190968000.0, "total_assets": 220537000.0, "total_liabilities": 29569000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15483745967910853, "net_margin": 0.8110627445807501, "operating_margin": 0.33200168340651126, "revenue_growth_yoy": 0.9576862065149223, "roa_avg2y": 0.8926820837222165, "roa_period_end": 0.5854890562581335, "roe_avg2y": 1.1114582929842003, "roe_period_end": 0.6761446943990618 } }, { "accn": "0001628280-20-002122", "filed": "2020-02-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 194000.0, "cash": 51536000.0, "eps_diluted": 0.07, "free_cash_flow": 18197000.0, "net_income": 8140000.0, "operating_cash_flow": 18391000.0, "operating_income": 10179000.0, "revenue": 81321000.0, "stockholders_equity": 41379000.0, "total_assets": 68753000.0 }, "period_end": "2016-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.10009714587867831, "operating_margin": 0.12517062013502048, "roa_period_end": 0.11839483367998488, "roe_period_end": 0.19671814205273205 } } ], "latest_filing": { "accn": "0001628280-26-011091", "filed": "2026-02-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001088856.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001088856.json" }, "ticker": "CORT" }